
Dr. Christopher Schaber is the President and CEO of Soligenix, a late stage biopharmaceutical company with a pipeline of pharmaceutical products to treat a variety of rare diseases with an unmet […]
We interview CEOs as well as Key Opinion Leaders across the spectrum who are engaged in pursuing cures for cancers.
Dr. Christopher Schaber is the President and CEO of Soligenix, a late stage biopharmaceutical company with a pipeline of pharmaceutical products to treat a variety of rare diseases with an unmet […]
Dr. Amit Vohra is the founder & CEO of Promaxo, a company tackling prostate disease management through the development of an office-based MRI. Brett Johnson interviewed Dr. Vohra to find out in […]
As Senior Vice President of Strategic Initiatives at the New York Stem Cell Foundation, Stephen Chang is one of the leading experts in gene therapy and neurodegenerative. Dr. Chang speaks with Brett […]
OmniCyte Founder, Peter Leonardi, provides insight into the emerging field of immunotherapy. Immunotherapy is the process that uses the body’s natural defense system to cure cancer. The most popular area is in […]